Synopsis
0
CEP/COS
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
A Naftopidil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naftopidil, including repackagers and relabelers. The FDA regulates Naftopidil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naftopidil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Naftopidil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Naftopidil supplier is an individual or a company that provides Naftopidil active pharmaceutical ingredient (API) or Naftopidil finished formulations upon request. The Naftopidil suppliers may include Naftopidil API manufacturers, exporters, distributors and traders.
click here to find a list of Naftopidil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Naftopidil DMF (Drug Master File) is a document detailing the whole manufacturing process of Naftopidil active pharmaceutical ingredient (API) in detail. Different forms of Naftopidil DMFs exist exist since differing nations have different regulations, such as Naftopidil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Naftopidil DMF submitted to regulatory agencies in the US is known as a USDMF. Naftopidil USDMF includes data on Naftopidil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Naftopidil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Naftopidil suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Naftopidil Drug Master File in Japan (Naftopidil JDMF) empowers Naftopidil API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Naftopidil JDMF during the approval evaluation for pharmaceutical products. At the time of Naftopidil JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Naftopidil suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Naftopidil Drug Master File in Korea (Naftopidil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Naftopidil. The MFDS reviews the Naftopidil KDMF as part of the drug registration process and uses the information provided in the Naftopidil KDMF to evaluate the safety and efficacy of the drug.
After submitting a Naftopidil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Naftopidil API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Naftopidil suppliers with KDMF on PharmaCompass.
A Naftopidil written confirmation (Naftopidil WC) is an official document issued by a regulatory agency to a Naftopidil manufacturer, verifying that the manufacturing facility of a Naftopidil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Naftopidil APIs or Naftopidil finished pharmaceutical products to another nation, regulatory agencies frequently require a Naftopidil WC (written confirmation) as part of the regulatory process.
click here to find a list of Naftopidil suppliers with Written Confirmation (WC) on PharmaCompass.
Naftopidil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Naftopidil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Naftopidil GMP manufacturer or Naftopidil GMP API supplier for your needs.
A Naftopidil CoA (Certificate of Analysis) is a formal document that attests to Naftopidil's compliance with Naftopidil specifications and serves as a tool for batch-level quality control.
Naftopidil CoA mostly includes findings from lab analyses of a specific batch. For each Naftopidil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Naftopidil may be tested according to a variety of international standards, such as European Pharmacopoeia (Naftopidil EP), Naftopidil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Naftopidil USP).
LOOKING FOR A SUPPLIER?
